Children's Oncology Group (COG) Trials for Retinoblastoma

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 491-495

  Meadows, Anna T ^a   Chintagumpala, Murali ^b   Dunkel, Ira J ^c   Friedman, Debra ^d   Stoner, Julie A ^e   Villablanca, Judith G ^f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEXAS CHILDREN S CANCER CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58049220345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50086-3     Document Type: Chapter

References (36)

1. Dyer MA, Bremner R The search for the retinoblastoma cell of origin. Nat Rev Cancer 2005, 5:91-101.
2. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000, 18:12-17.
3. Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996, 114:1348-1356.
4. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002, 133:657-664.
5. Knudson AG. Retinoblastoma and cancer genetics Chapter 65.
6. Murphree AL Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005, 18:41-53.
7. Schvartzman E, Chantada G, Fandino A, et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 1996, 14:1532-1536.
8. Messmer EP, Heinrich T, Hopping W, et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991, 98:136-141.
9. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer 1996, 77:1206-1213.
10. Shields CL, Shields JA, Baez KA, et al. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 1993, 77:544-548.
11. Uusitalo MS, Van Quill KR, Scott IU, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001, 119:41-48.
12. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002, 120:923-931.
13. Chantada GL, Dunkel IJ, de Davila MT, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?. Br J Ophthalmol 2004, 88:1069-1073.
14. Woolson RF Rank tests and a one-sample logrank test for comparing observed survival data to a standard population. Biometrics 1981, 37:687-696.
15. Jennison C, Turnbull BW Group sequential methods with application to clinical trials 2000, Chapman & Hall/CRC Press, Boca Raton, FL.
16. Anteby I, Ramu N, Gradstein L, et al. Ocular and orbital complications following the treatment of retinoblastoma. Eur J Ophthalmol 1998, 8:106-111.
17. Kaste SC, Chen G, Fontanesi J, et al. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol 1997, 15:1183-1189.
18. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005, 23:2272-2279.
19. Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004, 96:357-363.
20. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003, 21:2019-2025.
21. Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 1999, 17:569-577.
22. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996, 114:1321-1328.
23. Chan HSL, Heon, E., Budning, A. et al. Improvement of the cure rate of intraocular retinoblastoma without significantly increasing toxicity with higher dose carboplatin-teniposide in a cyclosporine multidrug reversal regimen. Proceedings 10th International Symposium on Retinoblastoma, 2001.
24. Villablanca JG, Atchaneeyasakul, L, Murphree, A.L. Clinical outcome of Group V eyes treated with cyclosporin A/carboplatin/etoposide/vincristine. Proceedings 10th International Symposium on Retinoblastoma, 2001.
25. Villablanca JG, Jubran RF, Murphree LA. Phase I study of subtenon carboplatin with systemic high dose carboplatin/etoposide/vincristine for eyes with disseminated intraocular retinoblastoma. Proceedings 10th International Symposium on Retinoblastoma, 2001.
26. Abramson DH, Frank CM, Dunkel IJ A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology 1999, 106:1947-1950.
27. Chantada G, Fandino A, Casak S, et al. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 2003, 40:15-161.
28. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, et al. Extraocular retinoblastoma: a 13-year experience. Cancer 2003, 98:1292-1298.
29. Namouni F, Doz F, Tanguy ML, et al. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 1997, 33:2368-2375.
30. Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000, 89:2117-2121.
31. Kremens B, Wieland R, Reinhard H, et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 2003, 31:281-284.
32. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of metastatic retinoblastoma. Ophthalmology 2003, 110:1237-1240.
33. Jubran RF, Erdreich-Epstein A, Butturini A, et al. Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. J Pediatr Hematol Oncol 2004, 26:31-34.
34. Matsubara H, Makimoto A, Higa T, et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant 2005, 35:763-766.
35. Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma: the experience of a single institution with 33 patients. Cancer 1994, 74:722-732.
36. Kivela T Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 1999, 17:1829-1837.